Position in FATE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$286,380
-$63,137 QoQ
Shares Held
238,650
-33.1% QoQ
Ownership
0.205%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Woodline Partners LP holds $3,424,016,489 across 189 Biotechnology names. FATE ranks #186 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,506,570 | $243,763,932 | |
| 2 | TNGX |
Tango Therapeutics, Inc.
|
8,000,013 | $167,360,271 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $149,053,834 | |
| 4 | QNCX |
Quince Therapeutics, Inc.
|
5,200,000 | $105,040,000 | |
| 5 | RCUS |
Arcus Biosciences, Inc.
|
3,777,798 | $81,600,436 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
243,883 | $80,693,568 | |
| 7 | SRRK |
Scholar Rock Holding Corp
|
1,500,470 | $73,763,105 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
758,891 | $66,000,750 |
All Filings in FATE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $286,380 | 238,650 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $349,517 | 356,650 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $897,939 | 712,650 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $798,168 | 712,650 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,125,091 | 1,424,167 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,347,595 | 1,422,785 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,730,114 | 3,065,747 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,286,566 | 1,002,002 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $13,887,294 | 1,892,002 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,441,261 | 385,364 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $476,266 | 100,056 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $570,022 | 100,004 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,621,644 | 160,718 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,601,690 | 160,718 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,982,592 | 160,718 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,231,036 | 160,718 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $11,647,936 | 199,076 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $9,065,761 | 152,957 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $11,378,689 | 131,106 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $10,418,382 | 126,360 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||